N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide

C49H96N2O9 — CID 162847361

IUPACN-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide
SMILESCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H](O)[C@H](O)CCCCCCCCCCCCC(C)C
InChIInChI=1S/C49H96N2O9/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-27-30-33-36-44(55)51-41(38-59-49-45(50-40(4)53)48(58)47(57)43(37-52)60-49)46(56)42(54)35-32-29-26-23-21-20-22-25-28-31-34-39(2)3/h39,41-43,45-49,52,54,56-58H,5-38H2,1-4H3,(H,50,53)(H,51,55)/t41-,42-,43-,45+,46-,47+,48-,49+/m1/s1
InChIKeyIWMKKWYZKOROBK-NDKGJBISSA-N
MW857.31 g/mol
LogP9.31
Rot. Bonds41

About N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide

N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide (PubChem CID 162847361) has the molecular formula C49H96N2O9 and a molecular weight of 857.31 g/mol. Its IUPAC name is N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide.

Molecular Properties

Compound NameN-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide
PubChem CID162847361
Molecular FormulaC49H96N2O9
Molecular Weight857.31 g/mol
Exact Mass856.71
IUPAC NameN-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide
SMILESCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H](O)[C@H](O)CCCCCCCCCCCCC(C)C
InChIInChI=1S/C49H96N2O9/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-27-30-33-36-44(55)51-41(38-59-49-45(50-40(4)53)48(58)47(57)43(37-52)60-49)46(56)42(54)35-32-29-26-23-21-20-22-25-28-31-34-39(2)3/h39,41-43,45-49,52,54,56-58H,5-38H2,1-4H3,(H,50,53)(H,51,55)/t41-,42-,43-,45+,46-,47+,48-,49+/m1/s1
InChIKeyIWMKKWYZKOROBK-NDKGJBISSA-N
XLogP9.31
TPSA177.81 Ų
H-Bond Donors7
H-Bond Acceptors9
Rotatable Bonds41
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500857.31
LogP ≤ 59.31
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide?
The IUPAC name of N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide (CID 162847361) is N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide.
What is the SMILES notation for N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide?
The canonical SMILES for N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide is CCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H](O)[C@H](O)CCCCCCCCCCCCC(C)C.
What is the InChIKey of N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide?
The InChIKey is IWMKKWYZKOROBK-NDKGJBISSA-N. The full InChI is InChI=1S/C49H96N2O9/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-27-30-33-36-44(55)51-41(38-59-49-45(50-40(4)53)48(58)47(57)43(37-52)60-49)46(56)42(54)35-32-29-26-23-21-20-22-25-28-31-34-39(2)3/h39,41-43,45-49,52,54,56-58H,5-38H2,1-4H3,(H,50,53)(H,51,55)/t41-,42-,43-,45+,46-,47+,48-,49+/m1/s1.
What are the key properties of N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide?
N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide has a molecular weight of 857.31 g/mol, XLogP of 9.31, 41 rotatable bonds, 7 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R,3R,4R)-1-[(2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]docosanamide is sourced from PubChem (CID 162847361), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).